Rocket Lab secures 20 additional launches for Synspective, while Citi initiates coverage with a Buy rating and $105 price ...

Citi downgrades Moderna to Sell from Hold, saying the data around its cancer vaccine, instimeran autogene, isn’t enough to ...

Citigroup is upgraded based on strong operating results and a somewhat improved starting valuation. Click to read more on the ...

The cancer pipeline gave Moderna's shares a rocket boost. Citi, however, just checked the stock’s price tag and wasn’t exactly impressed.

Citigroup is getting hit harder than Bank of America despite the legal headline landing at Merrill Lynch, and the gap between ...

Rocket Lab stock pushes higher on a bullish Citi note. Here’s why analyst John Godyn recommends buying RKLB shares.

Citi raised its Bitcoin target to $113,000 while forecasting just $5 billion of inflows. What has to go right for Bitcoin to ...

Citigroup stock falls 1.36% as Citi expands its Coinbase partnership with stablecoin payments, virtual accounts, and digital ...

Moderna stock MRNA fell nearly 6% in premarket trading on Wednesday after Citi downgraded the biotech company to ‘Sell’ from ...

Rocket Lab (RKLB) stock rises after Citi initiates a Buy rating and the company lands its largest-ever Electron launch deal.

Citigroup launches multi-market Swift payments as Citi stock slips 0.56%, expanding real-time cross-border access across key ...

Citi Wealth would have welcomed a deeper stock-market correction this year, seeing any bigger pullback as an opportunity to buy.